Abstract
The COVID-19 pandemic has dramatically changed lifestyles and quality of life (QoL) of the global population. Little is known regarding the psychological impact of the COVID-19 outbreak on patients with gastroenteropancreatic (GEP) or bronchopulmonary (BP) neuroendocrine tumors (NETs).
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have